Compare Sun Pharma with ALEMBIC PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUN PHARMA vs ALEMBIC PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUN PHARMA ALEMBIC PHARMA SUN PHARMA/
ALEMBIC PHARMA
 
P/E (TTM) x 31.9 15.7 202.9% View Chart
P/BV x 4.2 3.0 141.3% View Chart
Dividend Yield % 0.9 1.8 51.1%  

Financials

 SUN PHARMA   ALEMBIC PHARMA
EQUITY SHARE DATA
    SUN PHARMA
Mar-21
ALEMBIC PHARMA
Mar-21
SUN PHARMA/
ALEMBIC PHARMA
5-Yr Chart
Click to enlarge
High Rs6541,150 56.8%   
Low Rs339527 64.3%   
Sales per share (Unadj.) Rs139.6274.4 50.9%  
Earnings per share (Unadj.) Rs9.556.7 16.8%  
Cash flow per share (Unadj.) Rs18.266.0 27.5%  
Dividends per share (Unadj.) Rs7.5014.00 53.6%  
Avg Dividend yield %1.51.7 90.5%  
Book value per share (Unadj.) Rs193.6260.9 74.2%  
Shares outstanding (eoy) m2,399.34196.56 1,220.7%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x3.63.1 116.3%   
Avg P/E ratio x52.114.8 352.4%  
P/CF ratio (eoy) x27.312.7 214.8%  
Price / Book Value ratio x2.63.2 79.7%  
Dividend payout %78.824.7 319.1%   
Avg Mkt Cap Rs m1,190,430164,818 722.3%   
No. of employees `000NANA-   
Total wages/salary Rs m68,62210,512 652.8%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m334,98153,931 621.1%  
Other income Rs m8,592875 982.1%   
Total revenues Rs m343,57354,806 626.9%   
Gross profit Rs m41,61614,801 281.2%  
Depreciation Rs m20,8001,835 1,133.7%   
Interest Rs m1,414160 882.8%   
Profit before tax Rs m27,99413,681 204.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5,1472,533 203.2%   
Profit after tax Rs m22,84711,148 204.9%  
Gross profit margin %12.427.4 45.3%  
Effective tax rate %18.418.5 99.3%   
Net profit margin %6.820.7 33.0%  
BALANCE SHEET DATA
Current assets Rs m304,42125,779 1,180.9%   
Current liabilities Rs m161,45612,808 1,260.6%   
Net working cap to sales %42.724.1 177.5%  
Current ratio x1.92.0 93.7%  
Inventory Days Days14923 634.5%  
Debtors Days Days9924 418.5%  
Net fixed assets Rs m336,68241,311 815.0%   
Share capital Rs m2,399393 610.4%   
"Free" reserves Rs m462,22950,883 908.4%   
Net worth Rs m464,62851,276 906.1%   
Long term debt Rs m8,9811,999 449.3%   
Total assets Rs m641,10367,090 955.6%  
Interest coverage x20.886.4 24.1%   
Debt to equity ratio x00 49.6%  
Sales to assets ratio x0.50.8 65.0%   
Return on assets %3.816.9 22.5%  
Return on equity %4.921.7 22.6%  
Return on capital %6.226.0 23.9%  
Exports to sales %066.8 0.0%   
Imports to sales %012.7 0.0%   
Exports (fob) Rs mNA36,020 0.0%   
Imports (cif) Rs mNA6,845 0.0%   
Fx inflow Rs m84,49336,020 234.6%   
Fx outflow Rs m30,3346,845 443.2%   
Net fx Rs m54,15929,175 185.6%   
CASH FLOW
From Operations Rs m61,70414,634 421.7%  
From Investments Rs m5,362-8,388 -63.9%  
From Financial Activity Rs m-59,805-5,974 1,001.1%  
Net Cashflow Rs m5,964262 2,273.8%  

Share Holding

Indian Promoters % 54.7 69.0 79.3%  
Foreign collaborators % 0.0 0.5 -  
Indian inst/Mut Fund % 32.8 16.9 193.7%  
FIIs % 12.7 5.5 230.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 45.3 30.5 148.5%  
Shareholders   653,359 123,059 530.9%  
Pledged promoter(s) holding % 6.4 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUN PHARMA With:   AJANTA PHARMA  VIVIMED LABS  PARENT.DRUGS  BACIL PHARMA  VAISHALI PHARMA   



Today's Market

Sensex Ends 456 Points Lower; Midcap and Smallcap Stocks Witness Heavy Selling(Closing)

After opening the day on a flat note, Indian share markets witnessed heavy selling in the afternoon session and ended lower.

Related Views on News

SUN PHARMA 2020-21 Annual Report Analysis (Annual Result Update)

Oct 20, 2021 | Updated on Oct 20, 2021

Here's an analysis of the annual report of SUN PHARMA for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.

ALEMBIC PHARMA 2020-21 Annual Report Analysis (Annual Result Update)

Jul 8, 2021 | Updated on Jul 8, 2021

Here's an analysis of the annual report of ALEMBIC PHARMA for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of ALEMBIC PHARMA. Also includes updates on the valuation of ALEMBIC PHARMA.

SUN PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 87.4% (Quarterly Result Update)

Feb 1, 2021 | Updated on Feb 1, 2021

For the quarter ended December 2020, SUN PHARMA has posted a net profit of Rs 19 bn (up 87.4% YoY). Sales on the other hand came in at Rs 88 bn (up 8.4% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 13.8% (Quarterly Result Update)

Jan 19, 2021 | Updated on Jan 19, 2021

For the quarter ended December 2020, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 13.8% YoY). Sales on the other hand came in at Rs 13 bn (up 8.7% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

SUN PHARMA 2019-20 Annual Report Analysis (Annual Result Update)

Dec 11, 2020 | Updated on Dec 11, 2020

Here's an analysis of the annual report of SUN PHARMA for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.

More Views on News

Most Popular

Is it Time to Switch from Tata Power to NTPC?(Profit Hunter)

Oct 11, 2021

Given the huge run up in Tata Power, does it make sense to switch to NTPC?

This Proxy EV Stock Just got a Power Crisis Boost(Profit Hunter)

Oct 8, 2021

After months of research, I've come across few stocks that excite me far more than the mainstream electric vehicle companies.

Rs 1 Lakh Invested in These Cryptos at the Start of 2021 Became Rs...(Views On News)

Oct 8, 2021

These cryptos would have multiplied investors' wealth by as much as 10,000% in just nine months.

5 Exciting 'Unlisted' Companies and How to Play Them(Views On News)

Oct 7, 2021

Here's how you can invest in some of the most exciting start-ups of the decade.

Modi's Big Move Could Boost these 5 Defence Stocks(Views On News)

Oct 11, 2021

To corporatise the defence sector, the Ministry of Defence (MoD) has dissolved the 250-year-old Ordnance Factory Board (OFB).

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SUN PHARMA SHARE PRICE


Oct 20, 2021 (Close)

TRACK SUN PHARMA

  • Track your investment in SUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SUN PHARMA 8-QTR ANALYSIS

COMPARE SUN PHARMA WITH

MARKET STATS